ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Acrivon Therapeutics
The Clinical Trial Manager at Acrivon Therapeutics will lead the oversight of the ARC-386 Phase II clinical trial, managing all aspects from start-up through close-out. This role involves coordinating with investigator sites, CROs, vendors, and cross‑functional teams to ensure GCP/ICH compliance, budget control, and timely delivery of trial milestones.
Headquarters
Cambridge, Massachusetts, United States
Company Size
11-50 employees
Founded
2018
Acrivon Therapeutics is a clinical-stage biopharmaceutical company focused on precision oncology, developing targeted therapies designed to improve outcomes for cancer patients. The company leverages its proprietary AP3 platform, a proteomics-based patient selection method, to match drug mechanisms to the biological drivers of cancer and identify patients whose tumors are predicted to be sensitive to its drug candidates. Its pipeline includes ACR-368 (Prexasertib), a CHK1/2 kinase inhibitor in Phase 2 development, as well as internally developed candidates ACR-2316 and ACR-6840, targeting DNA Damage Response, cell cycle, and transcriptional regulators.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Acrivon Therapeutics.
Right around the average for this role